Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$3.10

0.42 (15.67%)

11:18
08/09/18
08/09
11:18
08/09/18
11:18

Rigel's early Tavalisse launch data 'a pleasant surprise,' says H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis notes that Rigel Pharmaceuticals announced Q2 results and, following the May 29 launch of Tavalisse, reported revenue for four weeks for the quarter of $1.8M, compared with his estimate of $140k and consensus of $180k, representing an encouraging beat with only this small time of selling. The analyst believes that having the full sales and marketing infrastructure in place at the time of launch contributed greatly to the early success. He reiterates a Buy rating and $7.50 price target on the shares.

RIGL Rigel Pharmaceuticals
$3.10

0.42 (15.67%)

08/08/18
PIPR
08/08/18
NO CHANGE
Target $8
PIPR
Overweight
Rigel Pharmaceuticals offered 'encouraging' Tavalisse update, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $8 price target on Rigel Pharmaceuticals, saying the company's Q2 earnings report also indicated a "highly encouraging initial update on the Tavalisse launch". Citing the drug's "relatively low payer snag, limited need for free drug, and encouraging mix of later and earlier stage patient", the analyst contends that the program is off to a "great start", maintaining his sales model of over $200M by 2022 and over $300M by 2025.
07/19/18
JEFF
07/19/18
NO CHANGE
Target $7
JEFF
Buy
Jefferies sees 'more rapid' uptake for Rigel's Tavalisse after hematologist poll
Jefferies analyst Eun Yang says her poll of 30 U.S. hematologists points to more rapid uptake for Rigel Pharmaceuticals' Tavalisse uptake and likely upside to current estimates. The survey is "particularly interesting" in light of the recent market selloff on launch, as it suggests the launch, especially in medium term, should go "very well," Yang tells investors in a research note. The poll results indicate potentially earlier/consistent use of Tavalisse as hematologists become more familiar with the drug, she adds. Yang has a Buy rating on Rigel with a $7 price target.
05/01/18
PIPR
05/01/18
NO CHANGE
Target $8
PIPR
Overweight
Rigel Pharmaceuticals price target raised to $8 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond raised his price target on Rigel Pharmaceuticals to $8 from $7 following the company's Q1 update and its discussions around the launch plans for Tavalisse. The analyst says the update was necessary to demonstrate the company's ability to execute commercially. Raymond keeps his Overweight rating on Rigel Pharmaceuticals.
04/25/18
PIPR
04/25/18
NO CHANGE
Target $7
PIPR
Overweight
Rigel share offering removes overhang, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond believes last week's follow-on offering removes an overhang on shares of Rigel Pharmaceuticals. The capital raise clears the way for what will be a "meaningful update" when Rigel reports earnings on May 1, and provides more detail on the upcoming Tavalisse launch plans, Raymond tells investors in a research note. He remains a buyer of the stock with an Overweight rating and $7 price target.

TODAY'S FREE FLY STORIES

FDX

FedEx

$181.50

-0.92 (-0.50%)

18:45
03/19/19
03/19
18:45
03/19/19
18:45
Hot Stocks
FedEx CEO: Domestic business is pretty good »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

LYFT

Lyft

$0.00

(0.00%)

18:41
03/19/19
03/19
18:41
03/19/19
18:41
Periodicals
Lyft IPO oversubscribed so far, Reuters reports »

Lyft's IPO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

NSTG

NanoString

$24.27

-3.03 (-11.10%)

18:37
03/19/19
03/19
18:37
03/19/19
18:37
Syndicate
NanoString 4.5M share Secondary priced at $23.00 »

JPMorgan, UBS and Cowen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

GLD

SPDR Gold Shares

$123.39

0.35 (0.28%)

18:37
03/19/19
03/19
18:37
03/19/19
18:37
Hot Stocks
Breaking Hot Stocks news story on SPDR Gold Shares »

SPDR Gold Shares holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.11

-0.03 (-0.05%)

18:33
03/19/19
03/19
18:33
03/19/19
18:33
Hot Stocks
Norwegian Cruise Line CEO: There is no recession »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NTNX

Nutanix

$38.78

0.425 (1.11%)

18:23
03/19/19
03/19
18:23
03/19/19
18:23
Hot Stocks
Nutanix CEO: Our churn is really small »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 04

    Apr

  • 09

    Jul

FDX

FedEx

$181.50

-0.92 (-0.50%)

18:20
03/19/19
03/19
18:20
03/19/19
18:20
Earnings
FedEx says started FY19 expecting revenue to rise $6B, but will see $4.5B »

This implies FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

18:04
03/19/19
03/19
18:04
03/19/19
18:04
Hot Stocks
FDA approves Sage Therapeutics' Zulresso in PPD treatment »

The FDA approved Zulresso…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

FDX

FedEx

$181.50

-0.92 (-0.50%)

18:02
03/19/19
03/19
18:02
03/19/19
18:02
Hot Stocks
FedEx says reviewing capital expense plan for FY20 »

Sees FY19 effective tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

BAYRY

Bayer

$0.00

(0.00%)

17:58
03/19/19
03/19
17:58
03/19/19
17:58
Periodicals
Bayer to face liability in second phase of Roundup trial, Bloomberg says »

Bayer has lost the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FDX

FedEx

$181.50

-0.92 (-0.50%)

17:57
03/19/19
03/19
17:57
03/19/19
17:57
Hot Stocks
FedEx says higher operating costs likely to continue to impact results »

Says will know about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

GPRO

GoPro

$6.26

0.005 (0.08%)

17:51
03/19/19
03/19
17:51
03/19/19
17:51
Periodicals
GoPro rival China's Insta360 plans 2020 IPO, CNBC says »

GoPro rival Insta360,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

, AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

17:47
03/19/19
03/19
17:47
03/19/19
17:47
Hot Stocks
FedEx Co-CEO Carter says Amazon not a threat to future growth »

Says well placed to take…

FDX

FedEx

$181.50

-0.92 (-0.50%)

AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 26

    Mar

  • 01

    Apr

  • 02

    Apr

  • 04

    Apr

FRBA

First Bank

$11.41

-0.14 (-1.21%)

17:46
03/19/19
03/19
17:46
03/19/19
17:46
Hot Stocks
First Bank to acquire Grand Bank for $19.4M »

First Bank and Grand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$72.00

0.13 (0.18%)

17:42
03/19/19
03/19
17:42
03/19/19
17:42
Hot Stocks
Cognizant President Rajeev Mehta sells over $1.4M in company shares »

Cognizant President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ENT

Global Eagle

$1.16

-0.14 (-10.77%)

17:42
03/19/19
03/19
17:42
03/19/19
17:42
Downgrade
Global Eagle rating change  »

Global Eagle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

17:40
03/19/19
03/19
17:40
03/19/19
17:40
Hot Stocks
FedEx CEO Fred Smith says Q3 was a 'challenging quarter' »

Says "we're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

AMRS

Amyris

$3.88

0.05 (1.31%)

17:31
03/19/19
03/19
17:31
03/19/19
17:31
Hot Stocks
Amyris to delay filing 10-K, may have further financial reporting deficiences »

Amyris was unable to file…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$296.55

-1.105 (-0.37%)

17:22
03/19/19
03/19
17:22
03/19/19
17:22
Hot Stocks
Lockheed Martin awarded $264.66M contract modification for Korea F-35 program »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

QHC

Quorum Health

$1.89

-0.02 (-1.05%)

17:20
03/19/19
03/19
17:20
03/19/19
17:20
Hot Stocks
York Capital reports 8.18% passive stake in Quorum Health »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

UPS

UPS

$110.37

-0.31 (-0.28%)

, FDX

FedEx

$181.50

-0.92 (-0.50%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
UPS falls after peer FedEx reports downbeat Q3 results, cuts FY19 EPS view »

UPS (UPS) is dropping in…

UPS

UPS

$110.37

-0.31 (-0.28%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

  • 25

    Apr

BA

Boeing

$373.87

1.77 (0.48%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
Boeing awarded $326.3M Navy delivery order »

Boeing has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BAYRY

Bayer

$0.00

(0.00%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Periodicals
Bayer to face liability in second phase of Roundup trial, Bloomberg says »

Bayer has lost the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GD

General Dynamics

$170.72

-1.01 (-0.59%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Hot Stocks
General Dynamics' Electric Boat awarded $2B contract modification »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DIS

Disney

$109.97

-3.1 (-2.74%)

, TFCFA

21st Century Fox

$49.62

(0.00%)

17:14
03/19/19
03/19
17:14
03/19/19
17:14
Hot Stocks
Disney, 21st Century Fox say per share value of merger $51.572626 »

The Walt Disney Company…

DIS

Disney

$109.97

-3.1 (-2.74%)

TFCFA

21st Century Fox

$49.62

(0.00%)

TFCF

21st Century Fox

$49.61

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.